论文部分内容阅读
目的:了解新型冠状病毒肺炎（COVID-19）住院患者体表心电图异常情况。方法:对2020年1月20日至3月1日武汉大学中南医院收治的147例COVID-19患者的入院及出院体表心电图进行回顾性分析，按照患者的临床分型分为轻型/普通型组及重型/危重型组，比较两组患者的临床资料、实验室检查结果及入出院体表心电图等指标。结果:147例COVID-19患者中，轻型/普通型患者123例，重型/危重型患者24例。与轻型/普通型患者相比，重型/危重型患者年龄较大，炎性指标及心肌酶学指标明显升高，且室性早搏（16.7%对4.7%）、QTc间期延长（4.2%对0）、异常Q波（4.2%对0）、胸前导联R波递增不良（4.2%对0）、胸前导联/肢体导联低电压（9.1%对0）等体表心电图异常表现比例更大（n P均<0.05）。n 结论:重型/危重型COVID-19患者更容易出现体表心电图异常包括室性早搏、QTc间期延长、异常Q波、胸前导联R波递增不良、胸前导联/肢体导联低电压，提示可能与心肌损伤程度有关。对于出现异常心电图表现的COVID-19患者尤其是重症患者，应密切关注心电图变化，预防不良心脏事件的发生。“,”Objective:To evaluate the abnormalities of body surface electrocardiogram in hospitalized patients with COVID-19.Methods:One hundred and forty-seven COVID-19 patients hospitalized in Zhongnan Hospital of Wuhan University from January 20, 2020 to March 1, 2020 were included. Based on the clinical classification, these patients were classified into two groups: mild/common group and critical/severe group. Demographic, laboratory data and body surface electrocardiogram were compared between the two groups.Results:One hundred and forty-seven COVID-19 patients (24 in critical/severe group and 123 in mild/common group) were finally included in this study. Compared with those in mild/common group, critical/severe group were older and in higher levels of markers of inflammation and myocardial enzyme. Moreover, ventricular premature beat (16.7% vs. 4.7%) , QTc prolongation (4.2% vs. 0) , equipotential Q wave (4.2% vs. 0) , poor R wave progression in the precordial leads (4.2% vs. 0) and low-voltage in limb/chest leads (9.1% vs. 0) were more frequent in critical/severe group than in mild/common group.Conclusion:Abnormal body surface electrocardiograms including ventricular premature beats, QTc prolongation, abnormal Q wave, poor R wave progression in the precordial leads and low-voltage in limb/chest leads were more frequent in critical/severe COVID-19 patients, which could be related to the degree of myocardial damage, indicating close attention should be paid to the changes of electrocardiograms in critical/severe COVID-19 patients to prevent adverse cardiac events.